+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vaccines Market Research Report by Indication (Anal Cancer, Cervical Cancer, and Genital Warts), Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 238 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4985895
UP TO OFF until Dec 31st 2022
The Global Vaccines Market size was estimated at USD 48.09 billion in 2021, USD 51.71 billion in 2022, and is projected to grow at a CAGR 7.69% to reach USD 75.02 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Indication, the market was studied across Anal Cancer, Cervical Cancer, Genital Warts, Oropharyngeal Cancer, Penile Cancer, Vaginal Cancer, and Vulvar Cancer.
  • Based on Distribution Channel, the market was studied across Government Entities, Physician Distributors, Physicians, Public & Private Alliances, and Wholesalers.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vaccines market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccines Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccines Market, including Abbott Laboratories Ltd, Astellas Pharma Inc., AstraZeneca PLC, Bharat Biotech International Limited, CSL Limited, Daiichi Sankyo Co., Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline PLC, Inovio Pharmaceuticals, Inc., Johnson & Johnson, Merck KGaA, Mitsubishi Tanabe Pharma Corporation, Novartis AG, Novavax, Inc., Panacea Biotec Ltd, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccines Market?
6. What is the market share of the leading vendors in the Global Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Vaccines Market?
Frequently Asked Questions about the Global Vaccines Market

What is the estimated value of the Global Vaccines Market?

The Global Vaccines Market was estimated to be valued at $48.09 Billion in 2021.

What is the growth rate of the Global Vaccines Market?

The growth rate of the Global Vaccines Market is 7.6%, with an estimated value of $75.02 Billion by 2027.

What is the forecasted size of the Global Vaccines Market?

The Global Vaccines Market is estimated to be worth $75.02 Billion by 2027.

Who are the key companies in the Global Vaccines Market?

Key companies in the Global Vaccines Market include Abbott Laboratories Ltd, Astellas Pharma Inc., AstraZeneca PLC, Bharat Biotech International Limited, CSL Limited, Daiichi Sankyo Co., Ltd., Emergent BioSolutions, Inc., GlaxoSmithKline PLC and Johnson & Johnson.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence of Infectious Diseases Globally
5.1.1.2. Favorable Government Initiatives and Policies for Vaccine Development
5.1.1.3. Growing Focus on Immunization Across the World
5.1.2. Restraints
5.1.2.1. High Capital Necessary for Vaccine Development
5.1.3. Opportunities
5.1.3.1. Emerging Initiatives from Companies in Research and Development of Vaccines
5.1.3.2. Integration of Adjuvants in Vaccines and Development of Therapeutic Vaccines
5.1.4. Challenges
5.1.4.1. Issues Over Product Recalls and Inaccessibility in Few Regions
5.2. Cumulative Impact of COVID-19
6. Vaccines Market, by Indication
6.1. Introduction
6.2. Anal Cancer
6.3. Cervical Cancer
6.4. Genital Warts
6.5. Oropharyngeal Cancer
6.6. Penile Cancer
6.7. Vaginal Cancer
6.8. Vulvar Cancer
7. Vaccines Market, by Distribution Channel
7.1. Introduction
7.2. Government Entities
7.3. Physician Distributors
7.4. Physicians
7.5. Public & Private Alliances
7.6. Wholesalers
8. Americas Vaccines Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Vaccines Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Vaccines Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. Fpnv Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abbott Laboratories Ltd
12.2. Astellas Pharma Inc.
12.3. Astrazeneca plc
12.4. Bharat Biotech International Limited
12.5. Csl Limited
12.6. Daiichi Sankyo Co., Ltd.
12.7. Emergent Biosolutions, Inc.
12.8. GlaxoSmithKline plc
12.9. Inovio Pharmaceuticals, Inc.
12.10. Johnson & Johnson
12.11. Merck KGaA
12.12. Mitsubishi Tanabe Pharma Corporation
12.13. Novartis Ag
12.14. Novavax, Inc.
12.15. Panacea Biotec Ltd
12.16. Pfizer Inc.
12.17. Sanofi Sa
12.18. Serum Institute of India Pvt. Ltd.
12.19. Takeda Pharmaceutical Company Limited
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINES MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL VACCINES MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL VACCINES MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINES MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL VACCINES MARKET DYNAMICS
FIGURE 8. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 9. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2027
FIGURE 11. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, 2019-2027 (USD BILLION)
FIGURE 22. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, 2019-2027 (USD BILLION)
FIGURE 24. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 26. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 28. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, 2019-2027 (USD BILLION)
FIGURE 35. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 36. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, 2019-2027 (USD BILLION)
FIGURE 37. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 38. AMERICAS VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 40. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2027
FIGURE 42. ARGENTINA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. BRAZIL VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. CANADA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. MEXICO VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. UNITED STATES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 48. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINES MARKET SIZE, BY STATE, 2027
FIGURE 50. ASIA-PACIFIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 52. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2027
FIGURE 54. AUSTRALIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. CHINA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. INDIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. INDONESIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. JAPAN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. MALAYSIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. PHILIPPINES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. SINGAPORE VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. SOUTH KOREA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. TAIWAN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. THAILAND VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2027
FIGURE 69. FRANCE VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. GERMANY VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. ITALY VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. NETHERLANDS VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. QATAR VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. RUSSIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. SAUDI ARABIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 76. SOUTH AFRICA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 77. SPAIN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. UNITED ARAB EMIRATES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 79. UNITED KINGDOM VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 80. GLOBAL VACCINES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 81. GLOBAL VACCINES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 82. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VACCINES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL VACCINES MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL VACCINES MARKET SIZE, BY ANAL CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS VACCINES MARKET SIZE, BY ANAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES VACCINES MARKET SIZE, BY ANAL CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC VACCINES MARKET SIZE, BY ANAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ANAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL VACCINES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS VACCINES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES VACCINES MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC VACCINES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL VACCINES MARKET SIZE, BY GENITAL WARTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS VACCINES MARKET SIZE, BY GENITAL WARTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES VACCINES MARKET SIZE, BY GENITAL WARTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC VACCINES MARKET SIZE, BY GENITAL WARTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GENITAL WARTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 22. AMERICAS VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. UNITED STATES VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY OROPHARYNGEAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL VACCINES MARKET SIZE, BY PENILE CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS VACCINES MARKET SIZE, BY PENILE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. UNITED STATES VACCINES MARKET SIZE, BY PENILE CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 29. ASIA-PACIFIC VACCINES MARKET SIZE, BY PENILE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PENILE CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL VACCINES MARKET SIZE, BY VAGINAL CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 32. AMERICAS VACCINES MARKET SIZE, BY VAGINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. UNITED STATES VACCINES MARKET SIZE, BY VAGINAL CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 34. ASIA-PACIFIC VACCINES MARKET SIZE, BY VAGINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VAGINAL CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. GLOBAL VACCINES MARKET SIZE, BY VULVAR CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 37. AMERICAS VACCINES MARKET SIZE, BY VULVAR CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. UNITED STATES VACCINES MARKET SIZE, BY VULVAR CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 39. ASIA-PACIFIC VACCINES MARKET SIZE, BY VULVAR CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VULVAR CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. GLOBAL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY GOVERNMENT ENTITIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY REGION, 2019-2027 (USD BILLION)
TABLE 48. AMERICAS VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY STATE, 2019-2027 (USD BILLION)
TABLE 50. ASIA-PACIFIC VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PHYSICIAN DISTRIBUTORS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. GLOBAL VACCINES MARKET SIZE, BY PHYSICIANS, BY REGION, 2019-2027 (USD BILLION)
TABLE 53. AMERICAS VACCINES MARKET SIZE, BY PHYSICIANS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. UNITED STATES VACCINES MARKET SIZE, BY PHYSICIANS, BY STATE, 2019-2027 (USD BILLION)
TABLE 55. ASIA-PACIFIC VACCINES MARKET SIZE, BY PHYSICIANS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PHYSICIANS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. GLOBAL VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY REGION, 2019-2027 (USD BILLION)
TABLE 58. AMERICAS VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. UNITED STATES VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY STATE, 2019-2027 (USD BILLION)
TABLE 60. ASIA-PACIFIC VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PUBLIC & PRIVATE ALLIANCES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. GLOBAL VACCINES MARKET SIZE, BY WHOLESALERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 63. AMERICAS VACCINES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. UNITED STATES VACCINES MARKET SIZE, BY WHOLESALERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC VACCINES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. AMERICAS VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. AMERICAS VACCINES MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. AMERICAS VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 70. AMERICAS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 71. ARGENTINA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 72. ARGENTINA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 73. ARGENTINA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 74. BRAZIL VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. BRAZIL VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 76. BRAZIL VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 77. CANADA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 78. CANADA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 79. CANADA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 80. MEXICO VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 81. MEXICO VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 82. MEXICO VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 83. UNITED STATES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. UNITED STATES VACCINES MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 85. UNITED STATES VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 86. UNITED STATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 87. ASIA-PACIFIC VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. ASIA-PACIFIC VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 90. ASIA-PACIFIC VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 91. AUSTRALIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. AUSTRALIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 93. AUSTRALIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 94. CHINA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. CHINA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 96. CHINA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 97. INDIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. INDIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 99. INDIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 100. INDONESIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. INDONESIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 102. INDONESIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 103. JAPAN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. JAPAN VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 105. JAPAN VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 106. MALAYSIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. MALAYSIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 108. MALAYSIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 109. PHILIPPINES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. PHILIPPINES VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 111. PHILIPPINES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 112. SINGAPORE VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. SINGAPORE VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 114. SINGAPORE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 115. SOUTH KOREA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. SOUTH KOREA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 117. SOUTH KOREA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 118. TAIWAN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. TAIWAN VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 120. TAIWAN VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 121. THAILAND VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 122. THAILAND VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 123. THAILAND VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 128. FRANCE VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. FRANCE VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 130. FRANCE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 131. GERMANY VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 132. GERMANY VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 133. GERMANY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 134. ITALY VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 135. ITALY VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 136. ITALY VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 137. NETHERLANDS VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 138. NETHERLANDS VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 139. NETHERLANDS VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 140. QATAR VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. QATAR VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 142. QATAR VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 143. RUSSIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 144. RUSSIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 145. RUSSIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 146. SAUDI ARABIA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 147. SAUDI ARABIA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 148. SAUDI ARABIA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 149. SOUTH AFRICA VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 150. SOUTH AFRICA VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 151. SOUTH AFRICA VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 152. SPAIN VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 153. SPAIN VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 154. SPAIN VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 155. UNITED ARAB EMIRATES VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 156. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 157. UNITED ARAB EMIRATES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 158. UNITED KINGDOM VACCINES MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 159. UNITED KINGDOM VACCINES MARKET SIZE, BY INDICATION, 2019-2027 (USD BILLION)
TABLE 160. UNITED KINGDOM VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 161. GLOBAL VACCINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 162. GLOBAL VACCINES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 163. GLOBAL VACCINES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 164. GLOBAL VACCINES MARKET RANKING
TABLE 165. GLOBAL VACCINES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 166. GLOBAL VACCINES MARKET MERGER & ACQUISITION
TABLE 167. GLOBAL VACCINES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 168. GLOBAL VACCINES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 169. GLOBAL VACCINES MARKET INVESTMENT & FUNDING
TABLE 170. GLOBAL VACCINES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 171. GLOBAL VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories Ltd
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bharat Biotech International Limited
  • CSL Limited
  • Daiichi Sankyo Co., Ltd.
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline PLC
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Merck KGaA
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Novavax, Inc.
  • Panacea Biotec Ltd
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...